Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.

The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM ... microenvironment are reflected in the peripheral blood lymphocyte count and peripheral blood ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

In the phase 3, randomized CARTITUDE-4 trial involving patients with lenalidomide-refractory multiple myeloma who had ... positive T-cell counts in peripheral blood (blue line) and soluble B ...

Complete blood count, genetic testing, and peripheral blood smear are the most commonly prescribed tests ... and can be accidentally found on routine checkups. Additionally, multiple other conditions ...

4 Peripheral blood smears reveal the characteristic elongation and sickling ... can detect either iron deficiency anemia or iron overload in patients who require multiple blood transfusions. 3 ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

But after a seemingly random finger fracture, his doctor tested him for elevated protein levels in his blood and told him he had a form of cancer called multiple myeloma. It was sort of an out-of ...

Chimeric antigen receptor T-cell therapy has been really instrumental in how we treat patients with myeloma. It has really changed the face of how we treat this disease, so since 2021, we've had two ...